Ryohei Kato

A Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor, UIC-94003 (TMC-126), and Selection of a Novel (A28S) Mutation in the Protease Active Site

Kazuhisa Yoshimura, Ryohei Kato, Mark F. Kavlick et al. · Journal of Virology · 2002 · 139 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1

Kazuhisa Yoshimura, Ryohei Kato, Keisuke Yusa et al. · Proceedings of the National Academy of Sciences · 1999 · 108 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing Allophenylnorstatine

Tsutomu Mimoto, Ryohei Kato, Haruo Takaku et al. · Journal of Medicinal Chemistry · 1999 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis of unnatural alkaloid scaffolds by exploiting plant polyketide synthase

Hiroyuki Morita, Makoto Yamashita, Shepo Shi et al. · Proceedings of the National Academy of Sciences · 2011 · 69 citations

Life Sciences, Biotechnology, Biocatalysis +15

Structural basis for the one-pot formation of the diarylheptanoid scaffold by curcuminoid synthase from <i>Oryza sativa</i>

Hiroyuki Morita, Kiyofumi Wanibuchi, Hirohiko Nii et al. · Proceedings of the National Academy of Sciences · 2010 · 56 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +14